NRG1 Gene Fusion

LUND, Sweden, July 1, 2026 Hansa Biopharma AB has completed its €115 million exclusive licensing transaction with SERB Pharmaceuticals...

LEXINGTON, Mass., July 2, 2026 Partner Therapeutics (PTx) has announced the publication of pivotal results from the Phase 2...